- The trend backdrop is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
RAINBOW
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Rainbow Children's Medicare Limited · Healthcare · Medical Care Facilities
Latest close
1,557 INR
2.1%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 19.9% above the Trend Line and sits at 89.9% of its 52-week range. The latest completed week returned 2.1%, after a 6.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 53/100.
Setup score
71
out of 100
Latest Close
1,557 INR
7 Aug 2026
1W Return
2.1%
latest completed week
4W Return
6.1%
short-term follow-through
12W Return
16.5%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.1%
Latest completed week; four-week move 6.1%.
Indicator stack
42/75
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
35 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 19.9% above the Trend Line and sits at 89.9% of its 52-week range. The latest completed week returned 2.1%, after a 6.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9112-week average 0.61
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.1% over four weeks, 16.5% over 12 weeks, and 6.0% over one year. The current trend has remained active for 8 consecutive weeks.
Performance by holding period
Active trend streak8 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.39Latest activity-pressure read.
Pressure change-3.8%Four-week change in activity pressure.
Leadership17.18Latest relative-leadership reading.
RS change41.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength35/100Blend of value, momentum, and quality. Underlying universe rank 66; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum68/100Medium-term price momentum. Underlying universe rank 33; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework27/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 56.7x Price divided by trailing earnings.
- Price / sales
- 9.3x Market value relative to trailing revenue.
- EV / EBITDA
- 28.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 86.7% Gross profit retained from each unit of revenue.
- Operating margin
- 23.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 11.9% Free cash flow generated from revenue.
- Return on invested capital
- 11.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.2% Latest one-year revenue growth.
- EPS growth
- 14.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -18.7% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.2% Cash dividends relative to market value.
- Buyback yield
- 0.1% Net share repurchases relative to market value.
- Shareholder yield
- 0.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 35 relevant articles.
4 positive · 30 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.3%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+8.7%Week of 10 Apr.
Worst week-5.6%Week of 13 Mar.
Latest week+2.1%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains11
Flat weeks0
Modest losses8
Sharp losses1
Recent vol2.7%13-week weekly-return volatility.
Base vol3.1%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank26 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank5 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape67/100
Trend, activity pressure, participation, and risk combine to a 67/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.91; 1 reversal markers Factors50/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 3; Small Cap Core rank 89 SVQF27/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1143.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 35 relevant articles.
Rainbow Childrens Medicare Q1 Results: Earnings Call Audio Released Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,557 INR | 2.1% | 1,299 INR | 1,319 INR | 1.39 | 17.18 | 761.1K | On |
| 31 Jul 2026 | 1,525 INR | 4.6% | 1,289 INR | 1,316 INR | 1.42 | 15.81 | 363.0K | On |
| 24 Jul 2026 | 1,458 INR | -2.2% | 1,282 INR | 1,313 INR | 1.43 | 13.59 | 301.4K | On |
| 17 Jul 2026 | 1,490 INR | 1.6% | 1,279 INR | 1,311 INR | 1.46 | 13.33 | 373.7K | On |
| 10 Jul 2026 | 1,467 INR | 2.1% | 1,273 INR | 1,308 INR | 1.44 | 12.18 | 551.1K | On |
| 3 Jul 2026 | 1,437 INR | 0.4% | 1,270 INR | 1,306 INR | 1.26 | 9.56 | 74.4K | On |
| 26 Jun 2026 | 1,431 INR | -2.5% | 1,267 INR | 1,303 INR | 1.13 | 9.98 | 0 | On |
| 19 Jun 2026 | 1,467 INR | 7.5% | 1,265 INR | 1,300 INR | 1.10 | 12.98 | 216.4K | On |
| 12 Jun 2026 | 1,365 INR | 1.6% | 1,260 INR | 1,297 INR | 1.05 | 6.97 | 72.4K | Off |
| 5 Jun 2026 | 1,343 INR | -2.7% | 1,259 INR | 1,294 INR | 1.16 | 6.43 | 76.8K | Off |
| 29 May 2026 | 1,380 INR | 1.9% | 1,260 INR | 1,291 INR | 1.31 | 8.57 | 535.8K | Off |
| 22 May 2026 | 1,355 INR | 1.4% | 1,260 INR | 1,288 INR | 1.22 | 5.88 | 548.5K | Off |
| 15 May 2026 | 1,336 INR | 2.4% | 1,260 INR | 1,286 INR | 1.15 | 4.85 | 995.0K | Off |
| 8 May 2026 | 1,304 INR | 4.2% | 1,261 INR | 1,283 INR | 1.04 | 0.18 | 1.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.